Biggest News Aggregation in the World
📰 Randomized Trial News

Page 13 - Randomized Trial News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Randomized Trial. Real-time updates on events, politics, business and more.

Gap Between Oxford COVID Doses can be Increased to 3 Months

Gap Between Oxford COVID Doses can be Increased to 3 Months by Angela Mohan on  February 22, 2021 at 12:07 PM The Lancet study. According to the findings from a phase 3 randomized controlled trial, the first dose offered 76 per cent protection in the three months between doses. The interval between doses can be safely extended to three months given the protection a single dose offers, which may allow countries to vaccinate a larger proportion of the population more rapidly, t...
Oxford University Oxford University Astrazeneca Covid 19 Oxford Doses 33 Months Controlled Trial

Conference Spotlights New Research to Benefit Primary Care

Conference Spotlights New Research to Benefit Primary Care Conference Spotlights New Research to Benefit Primary Care  Febuary 4, 2021, 3:24 pm News Staff — The talents of family medicine researchers from across the United States and elsewhere were on full display at the 48th annual meeting of the North American Primary Care Research Group, held virtually late last year. The meeting of more than 850 researchers gave attendees the opportunity to participate in more than 700 forums, oral pr...
United States Christina Hester Julie Sutter National Research Network Population Health University Of Colorado Department Family Medicine
Source: aafp.org

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Calquence approved in Japan for CLL

  relapsed or refractory chronic lymphocytic leukaemia   progression after 12 months vs. 68% for comparators   AstraZenecas Calquence (acalabrutinib), a next-generation, selective Brutons tyrosine kinase (BTK) inhibitor, has been approved in Japan for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukaemia (CLL) (including small lymphocytic lymphoma [SLL]).   The approval by the Japanese Ministry of Health, ...
Dai Maruyama Japan General United States United Kingdom Dave Fredrickson Acerta Pharma

Grand Rounds: Is It Time to Reconsider Ketorolac?

Grand Rounds is a monthly blog series developed by EMS World and FlightBridgeED that will feature top EMS medical directors exploring the intricacies of critical care in EMS practice. In this installment FlightBridgeED Chief Medical Officer Jeffrey Jarvis, MD, PM, reviews the drug ketorolac. Unless you’ve been very committed to keeping your head in the sand, you’ve probably noticed we’re in the midst of an opioid epidemic. Though there is little evidence that the one or two doses of IV o...
New York United States South Korea Sergey Motov Ketorolac Toradol Frederickr Ketorolac

Natural Remedies for Osteoarthritis: What Does and Doesn't Work

When you’re living with osteoarthritis (OA) pain that can’t be managed with conventional treatments alone, you may consider complementary therapies, too. “Traditional medicine is important,” says Deborah Ballard, M.D., a physician at Duke Integrative Medicine in Durham, NC. But it’s only one tool in the toolbox. Your best bet is to visit an integrative clinic, where you can get a customized healing plan, Dr. Ballard suggests. And whatever you decide to try—even if it’s an OTC supp...
United States Tai Chi Journal Of The American Geriatrics Society American College Of Rheumatology Knee Osteoarthritis Chronic Knee Pain Due

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science